Progranulin attenuated asthma inflammation by inhibiting the expression of IL-6

doi:10.12047/j.cjap.6126.2021.050

Abstract

Abstract: Objective: To investigate the role and mechanism of progranulin (PGRN) in asthma. Methods: Control group and model group were set up in wild and IL-6 knockout (IL-6 ko) mice, respectively. For asthma model, mice were intraperitoneally sensitized with 100 μg OVA on days 0 and 7, followed by aerosol challenges with 5% OVA for 30 min per day from day 14 to 21, and mice were sacrificed 24 h after the last challenge. The mice in control group were treated in the same way with PBS. Bronchoalveolar lavage fluid (BALF) was collected for leukocytes count and differential count. The pathological changes of lung tissues were observed by H&E staining. The cytokines in lung homogenate, serum and BALF were detected by Q-PCR and ELISA. The in vitro model of asthma was induced by stimulating A549 or BEAS-2B cells with IL-13. Each group was replicated in three wells and four groups were designed: PBS group, IL-13 treatment group, IL-13 + rhPGRN treatment group, inhibitors of p38 phosphorylation (SB203508) treatment group. The cells or supernatant were collected after 0~48 h. PGRN and IL-6 levels were determined by Q-PCR and ELISA, the level of p38 phosphorylation was tested by Western blot (WB). Results: Compared with control group, PGRN levels were decreased in lung homogenate and BALF (P＜0.05), and PGRN presented a downtrend in serum, however, the level of IL-6 in BALF was increased in asthma mice (P＜0.01). In IL-6 ko asthma mice, compared with the wild asthma mice, leukocytes, especially neutrophils in BALF were decreased (P＜0.05), but PGRN was increased (P＜0.05), lung pathological damage was significantly alleviated. In vitro experiments, compared with PBS group, PGRN level was decreased (P＜0.05), IL-6 level was increased (P＜0.01), phosphorylation of p38 was activated in IL-13 treatment group. Compared with IL-13 treatment group, in IL-13 + PGRN treatment group, IL-6 level was decreased (P＜0.05); phosphorylation of p38 was inhibited (P＜0.05); and the production of IL-6 (P＜0.05) was decreased after treatment with inhibitor of p38 phosphorylation. Conclusion: PGRN inhibited the production of IL-6 by suppressing the p38 phosphorylation to alleviate asthmatic airway inflammation.

Key words: mice, asthma, airway inflammation, PGRN, interleukin-6

CLC Number:

R392.8

QI Yu-hong, SUN Si, WANG Ling, YANG Jing, WU Guang-ying, HUANG Qi, XU Wen-chun. Progranulin attenuated asthma inflammation by inhibiting the expression of IL-6[J]. CJAP, 2021, 37(4): 423-428.

References 21

[1]	Chiba Y, Danno S, Suto R, et al. Intranasal administration of recombinant progranulin inhibits bronchial smooth muscle hyperresponsiveness in mouse allergic asthma [J]. Am J Physiol Lung Cell Mol Physiol, 2018, 314 (1): L215 -L223.
[2]	黄闯, 黄琨. 颗粒蛋白前体在炎症性疾病中的作用研究进展[J]. 细胞与分子免疫学杂志, 2016, 32(2): 268-271.
[3]	Park SY, Hong GH, Park S, et al. Serum progranulin as an indicator of neutrophilic airway inflammation and asthma severity[J]. Ann Allergy Asthma Immunol, 2016, 117(6): 646-650.
[4]	Choi GS, Trinh HKT, Yang EM, et al. Role of clusterin/progranulin in toluene diisocyanate-induced occupational asthma[J]. Exp Mol Med, 2018, 50(5): 1-10.
[5]	Hasegawa T, Uga H, Mori A, et al. Increased serum IL-17A and Th2 cytokine levels in patients with severe uncontrolled asthma[J]. Eur Cytokine Netw, 2017, 28(1): 8-18.
[6]	Li X, Hastie AT, Peters MC, et al. Investigation of the relationship between IL-6 and type 2 biomarkers in patients with severe asthma[J]. J Allergy Clin Immunol, 2020, 145(1): 430-433.
[7]	Tian R, Li Y, Yao X, et al. PGRN suppresses inflammation and promotes autophagy in keratinocytes through the Wnt/β-catenin signaling pathway[J]. Inflammation, 2016, 39(4): 1387-1394.
[8]	Wang C, Zhang L, Ndong JC, et al. Progranulin deficiency exacerbates spinal cord injury by promoting neuroinflammation and cell apoptosis in mice[J]. Neuroinflammation, 2019, 16 (1): 238-250.
[9]	Walker W, Healey GD, Hopkin JM, et al. RNA interference of STAT6 rapidly attenuates ongoing interleukin-13-mediated events in lung epithelial cells[J]. Immunology, 2009, 127(2): 256-266.
[10]	Yuan F, Liu R, Hu M, et al. JAX2, an ethanol extract of Hyssopus cuspidatus Boriss, can prevent bronchial asthma by inhibiting MAPK/NF-kappaB inflammatory signaling[J]. Phytomedicine, 2018, 57: 305-314.
[11]	Ungurs MJ, Sinden NJ, Stockley RA, et al. Progranulin is a substrate for neutrophil-elastase and proteinase-3 in the airway and its concentration correlates with mediators of airway inflammation in COPD [J]. Am J Physiol Lung Cell Mol Physiol, 2014, 306(1): L80-87.
[12]	Yin F, Banerjee R, Thomas B, et al. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice[J]. J Exp Med, 2010, 207(1): 117-128.
[13]	Koo DH, Park CY, Lee ES, et al. Progranulin as a prognostic biomarker for breast cancer recurrence in patients who had hormone receptor-positive tumors: a cohort study[J]. PLoS One, 2012, 7(6): e39880-39885.
[14]	Zhou J, Gao G, Crabb JW, et al. Purification of an autocrine growth factor homologous with mouse epithelin precursor from a highly tumorigenic cell line[J]. J Biol Chem, 1993, 268 (15): 10863-10869.
[15]	Qiu F, Song L, Ding F, et al. Expression level of the growth factor progranulin is related with development of systemic lupus erythematosus[J]. Diagn Pathol, 2013, 8 (1): 88-95.
[16]	Yamamoto Y, Takemura M, Serrero G, et al. Increased serum GP88 (Progranulin) concentrations in rheumatoid arthritis[J]. Inflammation, 2014, 37(5): 1806-1813.
[17]	Zou S, Luo Q, Song Z, et al. Contribution of progranulin to protective lung immunity during bacterial pneumonia[J]. J Infect Dis, 2017, 215(11): 1764-1773.
[18]	Vanaudenaerde BM, Wuyts WA, Dupont LJ, et al. Interleukin-17 stimulates release of interleukin-8 by human airway smooth muscle cells in vitro: a potential role for interleukin-17 and airway smooth muscle cells in bronchiolitis obliterans syndrome[J]. J Heart Lung Transplant, 2003, 22(11): 1280-1283.
[19]	Kishimoto T. IL-6: from its discovery to clinical applications[J]. Int Immunol, 2010, 22(5): 347-352.
[20]	江宏志, 吴为群, 严英硕, 等. 几种常见呼吸道疾病行气道反应性检测的临床意义[J]. 新医学, 2004, 35(11): 683-684.
[21]	Rincon M, Irvin CG. Role of IL-6 in asthma and other inflammatory pulmonary diseases[J].Int J Biol Sci, 2012, 8 (9): 1281-1290.